Trypanosoma cruzi trans-sialidase consists of a C-terminal domain composed essentially of immunodominant amino acid repeat units (SAPA-repeats) and an amino region responsible for the enzymatic activity (catalytic domain). To investigate the possible function(s) of SAPA-repeats, recombinant trans-sialidases either containing or lacking the C-terminal region were tested in mice. The presence of SAPA-repeats in the intravenously injected protein has two consequences. First, they enhance the persistence of the trans-sialidase activity in blood. Second, SAPA-repeats promoted the production of antibodies directed to the catalytic domain that inhibit trans-sialidase activity. These results suggest that SAPA-repeats modulate the trans-sialidase activity in blood.
Trypanosoma cruzi, the protozoan agent of Chagas' disease,
The C-terminal domain is made up of a variable number of immunodominant tandemly repeated 12-aa-long units termed expresses trans-sialidase, an enzyme able to transfer sialyl residues from the host's glycoconjugates to carbohydrate acceptors SAPA (for shed acute-phase antigen [14] ) not required for trans-sialidase activity [10, 11] . SAPA-repeats induce an early on the parasite surface (reviewed in [1, 2] ). Once sialylated, these glycoconjugates are thought to mediate binding to, and antibody response in acute [14] and congenital human infections [15] , as well as in animal infection models [2] . Antiinvasion of, mammalian cells [3, 4] . Sialylation of T. cruzi molecules is restricted to trans-sialidase activity, since the para-SAPA antibodies are detectable before the appearance of antibodies to the catalytic domain [9] , but they are ineffective at site is unable to synthesize sialic acids de novo [1] . In fact, it has been suggested that parasites lacking trans-sialidase are inhibiting trans-sialidase activity [16, 17] . Although many theories have been developed to explain unable to infect mammalian cells [5] and that the humoral response against this enzyme might be one of the factors conthe role of repetitive amino acid motifs in protozoan parasite antigens [1, 18 -20] , their function remain unknown. In the tributing to the survival of the infected host [6] .
trans-sialidase is anchored by glycosylphosphatidylinositol present work we make use of recombinant molecules either having or lacking the SAPA amino acid repeats in an attempt (GPI) to the surface membrane and shed into the blood by the infective form (trypomastigote) of the parasite [7 -9] . This to clarify the possible function(s) of the repetitive domain in T. cruzi trans-sialidase. enzyme seems to be a natural chimeric protein, containing both a 680-aa-long amino region responsible for the enzymatic activity (catalytic domain) [10, 11] and a C-terminal extension Materials and Methods (figure 1, top) [2] . Antibodies able to inhibit trans-sialidase activity are exclusively directed to the catalytic domain [9, 10] Cloning procedures. TS clone was obtained by EcoRI digesand have been found in sera from infected humans and animals tion of the TcTS611/2 clone [21] followed by subcloning on [9, 12, 13] .
pTrcHisA vector (Invitrogen, San Diego). For the TS-SAPA clone, the C-terminal extension obtained from a genomic clone was added to the TS clone by using the unique KpnI site [17, 21] . For the [22]. About 1 pmol of TS, TS-SAPA, or REPEATS protein corresialidase activity was measured as described [9] . Each serum sample was assayed in duplicate, and the TIA values in the figures sponds to 70, 100, and 60 ng, respectively. The presence of SAPArepeats in TS-SAPA and REPEATS proteins was demonstrated by are the means of these duplicate assays.
To determine the nature of the trans-sialidase inhibitory activity, Western blot with use of a monoclonal anti-SAPA antibody [9] .
Animals. C3H/HeN and Rockland mice, 60-90 days old, bred sera from TS-SAPA-immunized animals were fractionated on protein A-sepharose (Pharmacia) as described [9] , and both the in our own facilities were used. The strains and sexes of mice for each experiment are indicated in the figure legends.
flow-through and the fraction retained onto the column were tested for TIA. We found that normal mouse sera displayed a variable Immunization schedules. For intravenous (iv) immunization, animals were injected by the retroorbital sinus with TS, TS-SAPA, interference on trans-sialidase activity that was lost after several freezing/thawing cycles. Accordingly, at least 2 naive animals were or heat-denatured TS-SAPA protein contained in 150-200 mL of sterile PBS. trans-sialidase activity in blood was verified as desimultaneously bled and tested as controls for each assay, and these values are referred to as 0% TIA. scribed [9] in samples (5 mL of serum) collected from the tail at different times after inoculation. For intraperitoneal (ip) immunization, animals were injected with REPEATS, TS, TS-SAPA, or heat-denatured TS-SAPA protein previously adsorbed in alumin.
Results
Before inoculation, alumin-adsorbed TS and TS-SAPA samples were centrifuged, and trans-sialidase activity was measured in both
SAPA-repeats stabilize trans-sialidase activity in blood.
pellet and supernatants. More than 90% of the initial trans-sialidase Two recombinant trans-sialidases, either containing (TS-SAPA activity was found to be present in the pellet. For REPEATS protein) or lacking (TS protein) the C-terminal extension, were and heat-denatured TS-SAPA immunogens, which lack enzymatic constructed and purified (figure 1). Both proteins, when exactivity, adsorption to alumin was verified by PAGE. pressed in Escherichia coli, displayed a similar trans-sialidase Anti-SAPA-repeats antibodies assay. Polystyrene ELISA miactivity, indistinguishable from that of the natural enzyme [11] croplates (Maxisorp; Nunc, Roskilde, Denmark) were coated with (data not shown). 75 ng of purified REPEATS protein in 100 mL of PBS. Serum
Mice were inoculated iv either with TS-SAPA or TS protein, samples were tested in a 1/100 (vol/vol) dilution in Tris-buffered and trans-sialidase activity was monitored in serum samples saline (TBS) plus 3% bovine serum albumin (BSA; Sigma, St.
for several days after injection (figure 2A the antibody response against the molecule, mice were immuwas able to inhibit trans-sialidase activity, even after several boosters. In contrast, 7 of 9 mice injected with TS-SAPA pronized iv with either TS-SAPA or TS protein, and the antibody response against the catalytic domain was assayed (figure 3).
tein developed a response against trans-sialidase that blocked the enzymatic activity. Serum from only 1 of 11 animals immunized with TS protein ers (data not shown). We have previously demonstrated that the trans-sialidase Discussion inhibitory activity in sera from chronically infected humans and mice was due to antibodies directed to the enzymatic domain of Some protozoan parasites, such as Plasmodium species and the molecule [9] . To test if this was also the case in immunized T. cruzi, display a large variety and diversity of molecules animals, sera from 2 mice that inhibited trans-sialidase (inocucontaining repeated amino acid sequences [20, 23, 24] . Allated with TS-SAPA; figure 3, experiment 3) were fractionated though many theories have been developed [1, 18 -20] , their on a protein A column [9] . The purified immunoglobulins from possible role(s) remain elusive. These repetitive sequences are these 2 sera inhibited trans-sialidase by 99% and 95%, while usually immunodominant [14, 25] , probably because of the the protein A unbound fractions inhibited the enzymatic reacparticular arrangement of epitopes within these regions. It has tion by 8% and 36%.
been shown that B cells respond promptly to viral envelopes The trans-sialidase inhibitory response is accelerated in anibut fail to respond to the same epitopes when poorly organized, mals primed with SAPA-repeats. A group of mice was immufor instance, on the surface of infected cells [26] . Because nized by the ip route with purified SAPA-repeats protein (REof their immunodominance, it has been proposed that these PEATS clone; figure 1). Fifteen days later, when a strong antirepetitive sequences would act as a ''smoke screen,'' delaying SAPA-repeats response was observed (data not shown), mice or even preventing the formation of antibodies directed against were challenged iv with TS-SAPA protein. Antibodies inhibmolecules involved in the virulence of the parasite [20] . iting trans-sialidase were assayed after a single dose of antigen,
At variance with present views, SAPA-repeats in trans-sialiand the results were compared with those obtained after iv dase were found to promote the humoral response against other inoculation of a single dose of TS-SAPA in naive mice.
epitope(s) present in the catalytic domain able to inhibit the As shown in table 1, 5 of 6 mice primed with REPEATS trans-sialidase activity ( figure 3 ). Given the fact that this enzyprotein elicited a response inhibiting trans-sialidase after rematic activity is considered a T. cruzi virulence factor [5, 6], ceiving TS-SAPA, as evaluated on day 15 after challenge. On SAPA-repeats seems to promote instead of prevent the neutralthe other hand, none of naive animals challenged with TSization of a critical parasite molecule. These results were ob-SAPA developed an inhibitory response by day 15 after injectained in three independent experiments and seemed to be unretion. Thus, TS-SAPA generated a faster response in mice prelated to the genetic background of mice. viously immunized with SAPA-repeats than in control animals.
One of the mechanisms underlying the generation of the As expected, none of the animals primed with REPEATS prohumoral response inhibiting trans-sialidase mediated by tein and challenged iv with TS protein generated antibodies SAPA-repeats would be through the prior induction of antiinhibiting trans-sialidase ( in the same molecule that have not yet induced an antibody the humoral response is primarily driven against the repetitive domain [14, 15] , leading to the generation of immunocomresponse may be favored, resulting in B cell epitope spreading [27, 28] . Applied to the trans-sialidase model, a preferential plexes that retain trans-sialidase activity [16, 17] . In the second stage of a continuous process, these immunocomplexes might expansion of B cell populations recognizing epitope(s) within the catalytic domain after the determinants in SAPA-repeats promote the production of antibodies inhibiting trans-sialidase (table 1) . Thus, our hypothesis predicts that SAPA-repeats have have been blocked by soluble antibodies might be postulated (table 1) . a dual effect, first stabilizing the enzymatic activity in blood and then promoting the production of antibodies inhibiting Alternatively, it might be considered that SAPA-repeats contain a T cell epitope that helps in the production of antibodies trans-sialidase. This dual effect might constitute a novel mechanism selected for in the parasite-host interaction to modulate to the catalytic domain of the molecule [29] . Our results suggest that the catalytic domain itself should have B and T cell epithe infection [5, 6] and it may provide a defined function for some repetitive domains in parasite antigens. topes since TS protein alone stimulates the production of antibodies inhibiting trans-sialidase when ip inoculated with alumin as adjuvant (figure 4). However, these results do not exclude that the effect of preimmunization with SAPA-repeats
